メチシリン感受性黄色ブドウ球菌の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR3736)
◆英語タイトル:Global Methicillin-Susceptible Staphylococcus Aureus Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR3736
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:90
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥526,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥789,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、メチシリン感受性黄色ブドウ球菌の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(セファロスポリン、バンコマイシン、リネゾリド、その他)、用途別市場規模(病院、クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・メチシリン感受性黄色ブドウ球菌の市場動向
・企業の競争状況、市場シェア
・メチシリン感受性黄色ブドウ球菌の種類別市場規模(セファロスポリン、バンコマイシン、リネゾリド、その他)
・メチシリン感受性黄色ブドウ球菌の用途別市場規模(病院、クリニック、その他)
・メチシリン感受性黄色ブドウ球菌の北米市場規模2016-2027(アメリカ、カナダ)
・メチシリン感受性黄色ブドウ球菌の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・メチシリン感受性黄色ブドウ球菌のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・メチシリン感受性黄色ブドウ球菌の中南米市場規模2016-2027(メキシコ、ブラジル)
・メチシリン感受性黄色ブドウ球菌の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Dainippon Sumitomo Pharma Co., Ltd、Immtech Pharmaceuticals, Inc.、Lytix Biopharma AS、PharmaIN Corporation、Cubist Pharmaceuticals、Kenta Biotech AG、Arsanis Biosciences GmbH、Volcano Corporation、Abbott Laboratories、AngioScore Inc.)
・結論
【レポートの概要】

Methicillin-susceptible staphylococcus aureus infections are caused by gram-positive bacterium, which leads to skin allergies, pneumonia and endocarditis.

Market Analysis and Insights: Global Methicillin-Susceptible Staphylococcus Aureus Market
The global Methicillin-Susceptible Staphylococcus Aureus market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Methicillin-Susceptible Staphylococcus Aureus market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Methicillin-Susceptible Staphylococcus Aureus market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Methicillin-Susceptible Staphylococcus Aureus market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Methicillin-Susceptible Staphylococcus Aureus market.

Global Methicillin-Susceptible Staphylococcus Aureus Scope and Market Size
Methicillin-Susceptible Staphylococcus Aureus market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Methicillin-Susceptible Staphylococcus Aureus market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Treatment and by End Users in terms of revenue and forecast for the period 2016-2027.

Segment by Treatment
Cephalosporins
Vancomycin
Linezolid
Others

Segment by End Users
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Dainippon Sumitomo Pharma Co., Ltd
Immtech Pharmaceuticals, Inc.
Lytix Biopharma AS
PharmaIN Corporation
Cubist Pharmaceuticals
Kenta Biotech AG
Arsanis Biosciences GmbH
Volcano Corporation
Abbott Laboratories

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Treatment: 2016 VS 2021 VS 2027
1.2.2 Cephalosporins
1.2.3 Vancomycin
1.2.4 Linezolid
1.2.5 Others
1.3 Market by Application
1.3.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Share by End Users: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Perspective (2016-2027)
2.2 Methicillin-Susceptible Staphylococcus Aureus Growth Trends by Regions
2.2.1 Methicillin-Susceptible Staphylococcus Aureus Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Methicillin-Susceptible Staphylococcus Aureus Historic Market Share by Regions (2016-2021)
2.2.3 Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Regions (2022-2027)
2.3 Methicillin-Susceptible Staphylococcus Aureus Industry Dynamic
2.3.1 Methicillin-Susceptible Staphylococcus Aureus Market Trends
2.3.2 Methicillin-Susceptible Staphylococcus Aureus Market Drivers
2.3.3 Methicillin-Susceptible Staphylococcus Aureus Market Challenges
2.3.4 Methicillin-Susceptible Staphylococcus Aureus Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Revenue
3.1.1 Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Revenue (2016-2021)
3.1.2 Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Players (2016-2021)
3.2 Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Methicillin-Susceptible Staphylococcus Aureus Revenue
3.4 Global Methicillin-Susceptible Staphylococcus Aureus Market Concentration Ratio
3.4.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Methicillin-Susceptible Staphylococcus Aureus Revenue in 2020
3.5 Methicillin-Susceptible Staphylococcus Aureus Key Players Head office and Area Served
3.6 Key Players Methicillin-Susceptible Staphylococcus Aureus Product Solution and Service
3.7 Date of Enter into Methicillin-Susceptible Staphylococcus Aureus Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Methicillin-Susceptible Staphylococcus Aureus Breakdown Data by Treatment
4.1 Global Methicillin-Susceptible Staphylococcus Aureus Historic Market Size by Treatment (2016-2021)
4.2 Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Treatment (2022-2027)

5 Methicillin-Susceptible Staphylococcus Aureus Breakdown Data by End Users
5.1 Global Methicillin-Susceptible Staphylococcus Aureus Historic Market Size by End Users (2016-2021)
5.2 Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by End Users (2022-2027)

6 North America
6.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
6.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment
6.2.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2021)
6.2.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2022-2027)
6.2.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2027)
6.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users
6.3.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2021)
6.3.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2022-2027)
6.3.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2027)
6.4 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
6.4.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
6.4.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
7.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment
7.2.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2021)
7.2.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2022-2027)
7.2.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2027)
7.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users
7.3.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2021)
7.3.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2022-2027)
7.3.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2027)
7.4 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
7.4.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
7.4.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
8.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment
8.2.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2021)
8.2.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2022-2027)
8.2.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2027)
8.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users
8.3.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2021)
8.3.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2022-2027)
8.3.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2027)
8.4 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region
8.4.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
9.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment
9.2.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2021)
9.2.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2022-2027)
9.2.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2027)
9.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users
9.3.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2021)
9.3.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2022-2027)
9.3.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2027)
9.4 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
9.4.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
9.4.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
10.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment
10.2.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2021)
10.2.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2022-2027)
10.2.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2027)
10.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users
10.3.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2021)
10.3.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2022-2027)
10.3.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2027)
10.4 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
10.4.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Dainippon Sumitomo Pharma Co., Ltd
11.1.1 Dainippon Sumitomo Pharma Co., Ltd Company Details
11.1.2 Dainippon Sumitomo Pharma Co., Ltd Business Overview
11.1.3 Dainippon Sumitomo Pharma Co., Ltd Methicillin-Susceptible Staphylococcus Aureus Introduction
11.1.4 Dainippon Sumitomo Pharma Co., Ltd Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.1.5 Dainippon Sumitomo Pharma Co., Ltd Recent Development
11.2 Immtech Pharmaceuticals, Inc.
11.2.1 Immtech Pharmaceuticals, Inc. Company Details
11.2.2 Immtech Pharmaceuticals, Inc. Business Overview
11.2.3 Immtech Pharmaceuticals, Inc. Methicillin-Susceptible Staphylococcus Aureus Introduction
11.2.4 Immtech Pharmaceuticals, Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.2.5 Immtech Pharmaceuticals, Inc. Recent Development
11.3 Lytix Biopharma AS
11.3.1 Lytix Biopharma AS Company Details
11.3.2 Lytix Biopharma AS Business Overview
11.3.3 Lytix Biopharma AS Methicillin-Susceptible Staphylococcus Aureus Introduction
11.3.4 Lytix Biopharma AS Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.3.5 Lytix Biopharma AS Recent Development
11.4 PharmaIN Corporation
11.4.1 PharmaIN Corporation Company Details
11.4.2 PharmaIN Corporation Business Overview
11.4.3 PharmaIN Corporation Methicillin-Susceptible Staphylococcus Aureus Introduction
11.4.4 PharmaIN Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.4.5 PharmaIN Corporation Recent Development
11.5 Cubist Pharmaceuticals
11.5.1 Cubist Pharmaceuticals Company Details
11.5.2 Cubist Pharmaceuticals Business Overview
11.5.3 Cubist Pharmaceuticals Methicillin-Susceptible Staphylococcus Aureus Introduction
11.5.4 Cubist Pharmaceuticals Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.5.5 Cubist Pharmaceuticals Recent Development
11.6 Kenta Biotech AG
11.6.1 Kenta Biotech AG Company Details
11.6.2 Kenta Biotech AG Business Overview
11.6.3 Kenta Biotech AG Methicillin-Susceptible Staphylococcus Aureus Introduction
11.6.4 Kenta Biotech AG Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.6.5 Kenta Biotech AG Recent Development
11.7 Arsanis Biosciences GmbH
11.7.1 Arsanis Biosciences GmbH Company Details
11.7.2 Arsanis Biosciences GmbH Business Overview
11.7.3 Arsanis Biosciences GmbH Methicillin-Susceptible Staphylococcus Aureus Introduction
11.7.4 Arsanis Biosciences GmbH Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.7.5 Arsanis Biosciences GmbH Recent Development
11.8 Volcano Corporation
11.8.1 Volcano Corporation Company Details
11.8.2 Volcano Corporation Business Overview
11.8.3 Volcano Corporation Methicillin-Susceptible Staphylococcus Aureus Introduction
11.8.4 Volcano Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.8.5 Volcano Corporation Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Details
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Methicillin-Susceptible Staphylococcus Aureus Introduction
11.9.4 Abbott Laboratories Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.9.5 Abbott Laboratories Recent Development
11.10 AngioScore Inc.
11.10.1 AngioScore Inc. Company Details
11.10.2 AngioScore Inc. Business Overview
11.10.3 AngioScore Inc. Methicillin-Susceptible Staphylococcus Aureus Introduction
11.10.4 AngioScore Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.10.5 AngioScore Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ メチシリン感受性黄色ブドウ球菌の世界市場規模・現状・予測2021年-2027年(Global Methicillin-Susceptible Staphylococcus Aureus Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。